Evidence map›Paper›PMID 23921614›Full record

ArticleAIDS (London, England)2013

Contribution of HIV infection to mortality among cancer patients in Uganda.

Anna E Coghill, Polly A Newcomb, Margaret M Madeleine, Barbra A Richardson, Innocent Mutyaba, Fred Okuku, Warren Phipps, Henry Wabinga, Jackson Orem, Corey Casper

Open access · greenAbstract read
In one paragraph

Article in AIDS (London, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Human Immunodeficiency Virus-Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Anna E CoghillaFred Hutchinson Cancer Research Center bUniversity of Washington, Seattle, Washington cNational Cancer Institute, Bethesda, Maryland, USA dUCI/Hutchinson Cancer Center Alliance eKampala Cancer Registry, Kampala, Uganda.
Polly A Newcomb
Margaret M Madeleine
Barbra A Richardson
Innocent Mutyaba
Fred Okuku
Warren Phipps
Henry Wabinga
Jackson Orem
Corey Casper
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZADigital Research Alliance of CanadaFred Hutch Cancer Center · USUniversity of Washington · USDivision of Cancer Epidemiology and GeneticsUganda Cancer Institute · UG

Funding

VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
Developing Data-Driven Cancer ResearchersT32CA009168 · NCI · UNIVERSITY OF WASHINGTON · PI STEPHEN M SCHWARTZ, MICHAEL Chiao-An WU · 1985 to 2026
$10.1M
Human Herpesvirus-8 Replication and Kaposi Sarcoma Response to TreatmentK23CA150931 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PHIPPS, WARREN · 2011 to 2015
$714k
Association between HIV and Survival after Cancer DiagnosisR03CA153371 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 2010 to 2011
$173k
NCI NIH HHS K23 CA150931NCI NIH HHS R03 CA153371NCI NIH HHS T32 CA009168NCI NIH HHS T32 CA09168NIAID NIH HHS T32 AI007140
6 · The paper itself

Abstract

objectiveHIV infection is associated with cancer risk. This relationship has resulted in a growing cancer burden, especially in resource-limited countries where HIV is highly prevalent. Little is known, however, about how HIV affects cancer survival in these settings. We therefore investigated the role of HIV in cancer survival in Uganda.

designRetrospective cohort (N = 802).

methodsEligible cancer patients were residents of Kyadondo County, at least 18 years of age at cancer diagnosis, and diagnosed between 2003 and 2010 with one of the following: breast cancer, cervical cancer, non-Hodgkin's lymphoma, Hodgkin's lymphoma, or esophageal cancer. Patients were classified as HIV-infected at cancer diagnosis based on a documented positive HIV antibody test, medical history indicating HIV infection, or an HIV clinic referral letter. The primary outcome, vital status at 1 year following cancer diagnosis, was abstracted from the medical record or determined through linkage to the national hospice database. The risk of death during the year after cancer diagnosis was compared between cancer patients with and without evidence of HIV infection using Cox proportional hazards regression.

resultsHIV-infected cancer patients in Uganda experienced a more than two-fold increased risk of death during the year following cancer diagnosis compared to HIV-uninfected cancer patients [hazard ratio 2.28; 95% confidence interval (CI) 1.61-3.23]. This association between HIV and 1-year cancer survival was observed for both cancers with (hazard ratio 1.56; 95% CI 1.04-2.34) and without (hazard ratio 2.68; 95% CI 1.20-5.99) an infectious cause.

conclusionThis study demonstrates the role of HIV in cancer survival for both cancers with and without an infectious cause in a resource-limited, HIV-endemic setting.

Indexed as

AdolescentAdultAgedAged, 80 and overCohort StudiesFemaleHIV InfectionsHumansMaleMiddle AgedNeoplasmsRetrospective StudiesSurvival AnalysisUgandaYoung Adult

Identifiers

PMID23921614
PMCPMC4319357
OpenAlexW1999970830

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.